GLPG-1205

DB15346InvestigationalSmall molecule

GLPG-1205 is under investigation in clinical trial NCT03725852 (A Clinical Study to Test How Effective and Safe GLPG1205 is for Patients With Idiopathic Pulmonary Fibrosis (IPF)).

Mechanism: Pharmacologically active on G protein-coupled receptor 84
Curator reviewed
Formula / weight: C₂₂H₂₂N₂O₄ · 378.428 g/mol (avg)
Code names: GLPG-1205

Resolves to

Compound

UNIIK9WR6LRA5DCAS1445847-37-9ChEMBLCHEMBL3716365

Structure

InChIKeyIRBAWVGZNJIROV-SFHVURJKSA-NSMILESO=C1N=C(OC[C@@H]2COCCO2)C=C2N1CCC1=CC(=CC=C21)C#CC1CC1

Targets

Q9NQS5GPR84

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with GLPG-1205, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account